FINancial Toxicity and CAncer REcovery in YOUNG Adults
试验速览
- 阶段
- 不适用
- 状态
- Enrolling By Invitation
- 发起方
- 入组人数
- 300
- 试验地点
- 1
- 主要终点
- Financial toxicity
研究概览
简要总结
The FINCARE-Young study aims to investigate the extent and development of financial toxicity in adolescents and young adults with cancer. The primary purpose of this study is to assess the level of financial burden experienced during the acute phase of cancer treatment and after completion of therapy, and to analyze changes over time. In addition, the study seeks to identify sociodemographic, clinical, and socioeconomic factors associated with financial toxicity, as well as its impact on employment and social reintegration. By focusing on young adult cancer survivors, this study addresses an underexplored population and seeks to generate evidence to improve supportive care strategies and reduce long-term financial consequences of cancer.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Cross Sectional
入排标准
- 年龄范围
- 18 Years 至 50 Years（Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Age 18 to 39 years at the time of initial cancer diagnosis
- •Diagnosis of a malignant neoplasm
- •Receipt of oncological treatment at the University Medical Center Göttingen
- •Completion of primary cancer therapy at the time of study participation
- •Initial diagnosis between 2014 and 2024
- •Ability to provide informed consent
- •Sufficient German language skills to participate in a telephone interview and complete questionnaires
排除标准
- •Age below 18 years or above 39 years at the time of initial cancer diagnosis
- •No history of malignant disease
- •Ongoing primary cancer treatment at the time of study participation
- •Severe cognitive impairment or psychiatric condition preventing reliable participation
- •Insufficient German language proficiency to complete interviews or questionnaires
- •Withdrawal of informed consent
结局指标
主要结局
Financial toxicity
时间窗: From the acute phase of cancer treatment to the time of study participation after completion of therapy (retrospective assessment of treatment period and current assessment at follow-up), assessed only at one time point at study enrollment.
Financial toxicity, assessed using the Comprehensive Score for Financial Toxicity (COST) questionnaire, measured during the acute phase of cancer treatment and at the time of study participation, including change over time.
次要结局
未报告次要终点
研究者
Prof. Dr. Rami El Shafie
Prof. Dr.
University Medical Center Goettingen